Cargando…

c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer

FUT1 is a key rate-limiting enzyme in the synthesis of Lewis y, a membrane-associated carbohydrate antigen. The aberrant upregulation of FUT1 and Lewis y antigen is related to proliferation, invasion and prognosis in malignant epithelial tumors. A c-Fos/activator protein-1 (AP-1) binding site was fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Yingying, Zhu, Liancheng, Yan, Limei, Liu, Juanjuan, Liu, Dawo, Gao, Na, Tan, Mingzi, Gao, Song, Lin, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783580/
https://www.ncbi.nlm.nih.gov/pubmed/29130097
http://dx.doi.org/10.3892/or.2017.6052
_version_ 1783295302563790848
author Hao, Yingying
Zhu, Liancheng
Yan, Limei
Liu, Juanjuan
Liu, Dawo
Gao, Na
Tan, Mingzi
Gao, Song
Lin, Bei
author_facet Hao, Yingying
Zhu, Liancheng
Yan, Limei
Liu, Juanjuan
Liu, Dawo
Gao, Na
Tan, Mingzi
Gao, Song
Lin, Bei
author_sort Hao, Yingying
collection PubMed
description FUT1 is a key rate-limiting enzyme in the synthesis of Lewis y, a membrane-associated carbohydrate antigen. The aberrant upregulation of FUT1 and Lewis y antigen is related to proliferation, invasion and prognosis in malignant epithelial tumors. A c-Fos/activator protein-1 (AP-1) binding site was found in the FUT1 promoter. However, the mechanisms of transcriptional regulation of FUT1 remain poorly understood. TGF-β1 is positively correlated to Lewis y. In the present study, we investigated the molecular mechanism of FUT1 gene expression in response to TGF-β1. We demonstrated that c-Fos was highly expressed in 77.50% of ovarian epithelial carcinoma cases and was significantly correlated with Lewis y. Using luciferase activity and chromatin immunoprecipitation (ChIP) assay, we further revealed that c-Fos interacted with the FUT1 promoter in ovarian cancer cells and transcriptional capacity of the heterodimer formed by c-Fos and c-Jun was stronger than that of the c-Fos or c-Jun homodimers. Then, we demonstrated that TGF-β1 induced dose-dependent c-Fos expression, which was involved in TGF-β1-induced ovarian cancer cell proliferation. In addition, inhibition of MAPK activation or TGF-β1 receptor by pharmacological agents prevented TGF-β1-induced c-Fos and Lewis y expression. Silencing of c-Fos prevented TGF-β1-induced Lewis y expression. Collectively, the results of these studies demonstrated that TGF-β1 regulated FUT1 and Lewis y expression by activating the MAPK/c-Fos pathway.
format Online
Article
Text
id pubmed-5783580
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57835802018-02-12 c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer Hao, Yingying Zhu, Liancheng Yan, Limei Liu, Juanjuan Liu, Dawo Gao, Na Tan, Mingzi Gao, Song Lin, Bei Oncol Rep Articles FUT1 is a key rate-limiting enzyme in the synthesis of Lewis y, a membrane-associated carbohydrate antigen. The aberrant upregulation of FUT1 and Lewis y antigen is related to proliferation, invasion and prognosis in malignant epithelial tumors. A c-Fos/activator protein-1 (AP-1) binding site was found in the FUT1 promoter. However, the mechanisms of transcriptional regulation of FUT1 remain poorly understood. TGF-β1 is positively correlated to Lewis y. In the present study, we investigated the molecular mechanism of FUT1 gene expression in response to TGF-β1. We demonstrated that c-Fos was highly expressed in 77.50% of ovarian epithelial carcinoma cases and was significantly correlated with Lewis y. Using luciferase activity and chromatin immunoprecipitation (ChIP) assay, we further revealed that c-Fos interacted with the FUT1 promoter in ovarian cancer cells and transcriptional capacity of the heterodimer formed by c-Fos and c-Jun was stronger than that of the c-Fos or c-Jun homodimers. Then, we demonstrated that TGF-β1 induced dose-dependent c-Fos expression, which was involved in TGF-β1-induced ovarian cancer cell proliferation. In addition, inhibition of MAPK activation or TGF-β1 receptor by pharmacological agents prevented TGF-β1-induced c-Fos and Lewis y expression. Silencing of c-Fos prevented TGF-β1-induced Lewis y expression. Collectively, the results of these studies demonstrated that TGF-β1 regulated FUT1 and Lewis y expression by activating the MAPK/c-Fos pathway. D.A. Spandidos 2017-12 2017-10-23 /pmc/articles/PMC5783580/ /pubmed/29130097 http://dx.doi.org/10.3892/or.2017.6052 Text en Copyright: © Hao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Hao, Yingying
Zhu, Liancheng
Yan, Limei
Liu, Juanjuan
Liu, Dawo
Gao, Na
Tan, Mingzi
Gao, Song
Lin, Bei
c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer
title c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer
title_full c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer
title_fullStr c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer
title_full_unstemmed c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer
title_short c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer
title_sort c-fos mediates α1, 2-fucosyltransferase 1 and lewis y expression in response to tgf-β1 in ovarian cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783580/
https://www.ncbi.nlm.nih.gov/pubmed/29130097
http://dx.doi.org/10.3892/or.2017.6052
work_keys_str_mv AT haoyingying cfosmediatesa12fucosyltransferase1andlewisyexpressioninresponsetotgfb1inovariancancer
AT zhuliancheng cfosmediatesa12fucosyltransferase1andlewisyexpressioninresponsetotgfb1inovariancancer
AT yanlimei cfosmediatesa12fucosyltransferase1andlewisyexpressioninresponsetotgfb1inovariancancer
AT liujuanjuan cfosmediatesa12fucosyltransferase1andlewisyexpressioninresponsetotgfb1inovariancancer
AT liudawo cfosmediatesa12fucosyltransferase1andlewisyexpressioninresponsetotgfb1inovariancancer
AT gaona cfosmediatesa12fucosyltransferase1andlewisyexpressioninresponsetotgfb1inovariancancer
AT tanmingzi cfosmediatesa12fucosyltransferase1andlewisyexpressioninresponsetotgfb1inovariancancer
AT gaosong cfosmediatesa12fucosyltransferase1andlewisyexpressioninresponsetotgfb1inovariancancer
AT linbei cfosmediatesa12fucosyltransferase1andlewisyexpressioninresponsetotgfb1inovariancancer